Connect with us

BUSINESS

Synthetic MMJ Versus the Real Stuff

Published

on

CBD

When we use the term medical marijuana, we are referring to the entire unprocessed cannabis plant or its extracts for use as a pharmacological input in a treatment regime for individuals suffering from a variety of different health conditions. It may interest you to know that medical marijuana, at this point, only has explicit FDA approval as a safe and effective treatment for two conditions, both of which are severe and rare forms of epilepsy. Both of these conditions involve severe seizures and both of them represent conditions that no other pharmaceutical solution has been able to treat.

The established pharmaceutical version of medical marijuana that is used to treat these conditions is known as Epidiolex. This medication contains a pure form of CBD, and the FDA gave this approval in June 2018. Note it is also important to understand that the FDA has approved medications containing a synthetic version of THC known as Marinol and Cesamet. These drugs are used to treat nausea in people who are undergoing treatments for cancer and HIV. Interestingly, the FDA has not approved any marijuana-based drugs for the treatment of chronic or acute pain.

Synthetic versions of marijuana are often referred to as “Spice” or “K2”. According to the National Institute on drug abuse, synthetic marijuana is not considered marijuana. It is also not considered safe and is not recommended for any purpose. The important point to understand here is that synthetic marijuana attempts through chemical means to reproduce the essential function of marijuana as it interacts with human physiology. This runs up against what is known as the entourage effect – the idea that all of the elements of the cannabis plant work together in ways that supersede the impacts of just CBD or THC working alone.

Seen from this perspective, synthetic marijuana may not be nearly as effective and may have additional side effects that are difficult to account for.

Continue Reading
Advertisement

BUSINESS

Amfil Technologies Inc. (OTCMKTS:FUNN) Provides Updates On Reopening Snakes & Lattes Locations And Safety Measures Implemented

Published

on

Amfil Technologies Inc. (OTCMKTS:FUNN) has provided updates to shareholders regarding the Snakes & Lattes subsidiary and location reopening as well as the new safety procedures the company has implemented.

Following government regulations on combating the spread of COVID 19, the company had temporarily closed its physical Snakes & Lattes outlets in Ontario and Toronto as well as the fourth location in Tempe, Arizona. This was to combat the spread of the virus and protect customers and employees.

Amfil to reopen Snakes & Lattes Arizona

The company is now gearing up to reopen the Snakes & Lattes Tempe, Arizona location after restrictions in the state were lifted. On May 11, 2020, authorities in the state gave restaurants the go-ahead for their reopening, and the company is also preparing to reopen the location in Arizona, and employees have been trained on new safety procedures and protocols. Amfil indicated that from their observation, there has been incredible attendance at local locations, which has given the company confidence to move forward with the reopening.

Amfil told shareholders that they are expecting to reopen Toronto locations later this month, depending on the government’s authorization. During the period when the company had shuttered its locations temporarily, it received assistance from the US government through the PPP program and from the Canadian government through CEBA, and they expect more.

Amfil enhances safety protocols

According to the infection prevention and control measures (IPC), Amfil has a three-phased approach to opening for minimizing risk to customers and employees, exercising caution, and combating the spread of coronavirus. The phases include the first phase, which will be for delivery and takeout services only; the second phase will be opening for regular business but fewer hours and the final phase will be opening fully for business.

In all the phases, the company has included cleaning as well as sanitization measures and protocols. Also, the company will have more staff helping in cleaning protocols and increasing frequency of cleaning traffic areas like entrances, restrooms, and checkout counters heavily.

Continue Reading

BUSINESS

Orchid Ventures Inc. (OTCMKTS:ORVRF) Signs Licensing Agreement Of Licensing Orchid Brand In Various States

Published

on

Orchid Ventures Inc. (OTCMKTS:ORVRF) has announced the signing of a License Agreement for licensing its Oregon-based Orchid Essential Brand.

Orchid Ventures to sell Orchid Essential s distribution license in Oregon

As part of the transaction, the company will sell the OLCC distribution license issued to the Orchid Essentials facility located in Clackamas, Oregon. It includes the sale of rights for expansion to Oklahoma and Colorado but under a different agreement at a later date. The company buying the license will conduct its business under Orchid LLC, but ownership will be under Tine Trading Company, LLC.

An experienced management team leads the companies for a portfolio of vertically integrated, multi-state companies boasting of more than 10 years in manufacturing, cultivation as well as in retail dispensaries. Most importantly, the new leadership brings more than 30 years in the supply chain, manufacturing, and sales experience in the CPG and Food Service industry.

Following the signing of the agreement, it is expected that Orechid LLC will assume distribution and operational responsibilities in the state of Oregon within 45 days. In the coming month, Orchid will complete a development plan for production and introduction of Orchid Essential products in other states.

Orchid to receive $630,000 for the acquisition of Orchid Essentials

Tine Trading Company will pay Orchid a sum of $630,000 to purchase Orchid’s revenue and inventory at an Oregon facility as well as expansion rights to Oklahoma and Colorado. The payment will also include the opportunity of securing license rights for Orchid Essentials on other states. Orchid will receive license fees on the Orchid Essential sales for a ten-year term from Orechid, which will also acquire all packaging and vaporizer hardware through PurTec Delivery as part of the licensing deal.

Orchid CEO Corey Mangold indicated that this is a massive move in changing the Orchid Essentials’ business strategy l to a licensing model. He added that the chance to partner with Tine will give the company a way of establishing its licensing terms and infrastructure to expand their brand platform.

Continue Reading

BUSINESS

Mountain High Acquisitions Corp (OTCMKTS:MYHI) Completes Acquisition of GPS Associates

Published

on

Mountain High Acquisitions Corp (OTCMKTS:MYHI) has announced the completion of the acquisition of California-based GPS Associates Inc. GPS is a company that engages in the manufacture, formulation as well as distribution of CBD hemp products to its Santa Ana-based cGMP facility.

GPS produces various CBD formulations

The company comprises of top professionals that include herbalists, botanists, and chemists that are dedicated to combining premium organic CBD with other synergistic organic herbs to produce the high-quality pure product. GPS ensures that their products are tested to ascertain their purity and potency through third-party laboratories.

The CBD market is full of potential, and analysts indicate that by 2024 it will hit $20 billion sales. This is because there are several CBD applications in the market from various segments such as health products, cosmetics, pet products, pharmaceuticals, food, and beverages, as well as skincare.

Acquisition of GPS to help Mountain High succeed in CBD space

The company’s CEO Alan Smith indicated that there is massive potential in the CBD industry. He added that they expect demand for CBD products to increase, especially due to the stresses resulting from the coronavirus pandemic, thus creating accelerated growth.

For the company to be successful in the space, it has to have the right staff in terms of expertise, experience, and capital for differentiation, diversification, and distribution of products. Smith added that he is optimistic that the business combination with GPS will offer that winning formula in the fast-growing industry.

GPS’s fast-expanding product portfolio is distributed online, and the retail brand name of Zen Drops. It is also distributed via white label customers across the country. Paul Gaudreau, the CEO of GPS, stated that they believe in combining the power of organic herbs and hemp CBD in their formulations can optimize results. He added that the GPS team is currently developing new formulations as well as delivery systems. Gaudreau said that with the backing of Mountain High Acquisitions, they expect to diversify their product portfolio and enhance distribution.

Continue Reading



Trending Stories